KOBAYASHI Hirohito
Department School of Medicine(Tokyo Women's Medical University Adachi Medical Center), School of Medicine Position Associate Professor |
|
Article types | Original article |
Language | English |
Peer review | Peer reviewed |
Title | Immediate progressive disease in patients with metastatic renal cell carcinoma treated with nivolumab: a multi-institution retrospective study. |
Journal | Formal name:Targeted oncology Abbreviation:Target Oncol ISSN code:(1776-260X)1776-2596(Linking) |
Domestic / Foregin | Foregin |
Volume, Issue, Page | 13(5),pp.611-619 |
Author and coauthor | ISHIHARA Hiroki†, KONDO Tsunenori, TAKAGI Toshio, TACHIBANA Hirokazu, FUKUDA HIronori, YOSHIDA Kazuhiko, IIZUKA Jumpei, KOBAYASHI Hirohito, TANABE Kazunari |
Publication date | 2018/10 |
Summary | The development of immediate PD in mRCC patients treated with nivolumab can severely worsen patient prognosis. Sex, MSKCC score, and prior-line time to progression may be involved in the development of immediate PD. Prospective studies are needed to further assess these findings. |
DOI | 10.1007/s11523-018-0591-0 |
PMID | 30232691 |